Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

NCT00078221 is registered in ClinicalTrials.gov with OccuLogix as lead sponsor.

NCT NCT00078221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Lead sponsor
OccuLogix
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 1999
Completion date
December 31, 2005
Enrollment
180
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration